Company Performance Metrics
Eugene Melinyk: Co-founder and CEO- Eugene Melinyk: Co-founder ROMAD Holding ltd
Our name, ROMAD - RObust MAlware Defense, captures the essence of our innovative technology and unique capability.
ROMAD's patented Malware Genetic Sequencing™ technology enables us to identify, analyze, and stop in real time entire viral "families", as opposed to specific strains or individual variants. This ability allows
reliable, sustained detection and diffusion of a wide range of malware threats.
We detect what OTHERS MISS – because we’re not stuck in the perpetual arms race with malware developers, passively looking for their next creation just to figure out how to catch it next time.
We detect BEFORE others can – because we’re not waiting to analyze the new variant as a prerequisite to detection. Derivative strains and variants are just that - derivative. Our patent-pending family-based detection profiles let us cover the vast majority of derivatives on-the-fly.
We detect with the LEAST AMOUNT OF OVERHEAD, both on our team and on your endpoint – because unlike legacy platforms, we don’t need millions of individual static signatures to match the hundreds of thousands of derivative strains and variants created every day.
We detect WHERE others cannot – our Malware Genetics™ and dynamic threat response technology allows ROMAD to sustain detection capability virtually in perpetuity. Isolated industrial deployment scenarios such as SCADA, ICS, and IoT environments where updates are infrequent, yet viral threats prevalent (think Stuxnet model), are a perfect place for ROMAD endpoint threat detection and response capabilities.
We DISRUPT the criminal malware economic model by eliminating the critical time-to-detection gap – the opportunity to monetize the malware before detection is developed by legacy static-signature platforms. We eliminate the economic incentive for malware writers, kit builders, and bot herders, thereby contributing to the elimination of the vast majority of profit-driven malware presently in the wild.
Legacy anti-virus companies, dominated by outdated thinking and outmoded malware detection methods, chase their tales as they keep growing their analyst teams and bloating their signature sets into the hundreds of millions.
Then there’s ROMAD: an elegant, truly innovative, and uniquely capable platform specifically designed from the ground-up to address the actual root cause of the malware epidemic – the criminal malware economic model.
